The pathogenicity of cytomegalovirus

FEMS Microbiology Reviews

Volumn 23, Issue 4, 1999, Pages 457-482

  Sweet, Clive ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cytomegalovirus; Murine; Pathogenicity

Indexed keywords

VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HIGH RISK POPULATION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION; LATENT PERIOD; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; RECIPIENT; REVIEW; TISSUE SPECIFICITY; TRANSPLANTATION; VIRUS GENE; VIRUS MUTANT; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HERPESVIRIDAE INFECTIONS; HUMANS; MUROMEGALOVIRUS; VIRULENCE; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0033060142     PISSN: 01686445     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6445(99)00015-7     Document Type: Review

References (265)

1. Sweet, C. and Smith, H. (1990) The pathogenicity of viruses. In: Topley and Wilson's Principles of Bacteriology, Virology and Immunity, 8th edn., Vol. 4 (Collier, L.S. and Timbury, M.C., Eds.), pp. 105-130. Edward Arnold, London, UK.
2. Alford, C.A. and Britt, W.J. (1993) Cytomegalovirus. In: The Human Herpesviruses (Roizman, B., Whitley, R.J. and Lopez, C., Eds.), pp. 227-255. Raven Press, New York, USA.
3. Ho, M. (1991) Cytomegalovirus: Biology and Infection, 2nd edn., Plenum publishing, New York, USA.
4. Mocarski, E.S. (1993) Cytomegalovirus biology and replication. In: The Human Herpesviruses (Roizman, B., Whitley, R.J. and Lopez, C., Eds.), pp. 173-226. Raven Press, New York, USA.
5. Meier J.L., Stinski M.F. Regulation of human cytomegalovirus immediate-early gene expression. Intervirology. 39:1996;331-342.
6. Stenberg R.M. The human cytomegalovirus major immediate-early gene. Intervirology. 39:1996;333-349.
7. Spector D.H. Activation and regulation of human cytomegalovirus early genes. Intervirology. 39:1996;361-377.
8. Anders D.G., McCue L.A. The human cytomegalovirus genes and proteins required for DNA synthesis. Intervirology. 39:1996;378-388.
9. Cardin R.D., Abenes G.B., Stoddart C.A., Mocarski E.S. Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology. 209:1995;236-241.
10. Buhler B., Keil G.M., Weiland F., Koszinowski U.H. Characterization of the murine cytomegalovirus early transcription unit e1 that is induced by immediate-early proteins. J. Virol. 64:1990;1907-1919.
11. Dallas P.B., Lyons P.A., Hudson J.B., Scalzo A.A., Shellam G.R. Identification and characterization of a murine cytomegalovirus gene with homology to the UL25 open reading frame of human cytomegalovirus. Virology. 200:1994;643-650.
12. Elliott R., Clark C., Jaquish D., Spector D.H. Transcription analysis and sequence of the putative murine cytomegalovirus DNA polymerase gene. Virology. 185:1991;169-186.
13. Keil G.M., Ebelingkeil A., Koszinowski U.H. Immediate-early gene of murine cytomegalovirus - location, transcripts, and translation products. J. Virol. 61:1987;526-533.
14. Loh L.C., Britt W.J., Raggo C., Laferte S. Sequence analysis and expression of the murine cytomegalovirus phosphoprotein pp50, a homolog of the human cytomegalovirus UL44 gene product. Virology. 200:1994;413-427.
15. Messerle M., Keil G.M., Koszinowski U.H. Structure and expression of murine cytomegalovirus immediate-early gene-2. J. Virol. 65:1991;1638-1643.
16. Messerle M., Buhler B., Keil G.M., Koszinowski U.H. Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J. Virol. 66:1992;27-36.
17. Messerle M., Keil G.M., Schneider K., Koszinowski U.H. Characterization of the murine cytomegalovirus genes encoding the major DNA binding protein and the ICP18.5 homolog. Virology. 191:1992;355-367.
18. Rapp M., Messerle M., Buhler B., Tannheimer M., Keil G., Koszinowski U.H. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. J. Virol. 66:1992;4399-4406.
19. Rapp M., Lucin P., Messerle M., Loh L.C., Koszinowski U.H. Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus. J. Gen. Virol. 75:1994;183-188.
20. Xu J., Dallas P.B., Lyons P.A., Shellam G.R., Scalzo A.A. Identification of the glycoprotein H gene of murine cytomegaloviruses. J. Gen. Virol. 73:1992;1849-1854.
21. Chee M.S., Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R., Horsnell T., Hutchinson C.A., Kouzarides T., Martignetti J.A., Satchwell S.C., Tomlinson P., Weston K.M., Barrell B.G. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:1990;125-170.
22. Rawlinson W.D., Farrell H.E., Barrell B.G. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:1996;8833-8849.
23. Britt, W.J. and Alford, C.A. (1990) Cytomegalovirus. In: Fields Virology (Fields, B.N., Knipe, D.M. and Hartley, P.M., Eds.), pp. 2493-2523. Lippincott-Raven, Philadelphia, MS, USA.
24. Bruggeman C.A. Cytomegalovirus and latency: an overview. Virchows Arch. B-Cell. Pathol. Mol. Pathol. 64:1993;325-333.
25. Sinzger C., Jahn G. Human cytomegalovirus cell tropism and pathogenesis. Intervirology. 39:1996;302-319.
26. Stoddart C.A., Cardin R.D., Boname J.M., Manning W.C., Abenes G.B., Mocarski E.S. Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68:1994;6243-6253.
27. Bevan I.S., Sammons C.C., Sweet C. Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction. J. Med. Virol. 48:1996;308-320.
28. Rinaldo C.R., Black P.H., Hirsch M.S. Interactions of cytomegalovirus with leucocytes from patients with mononucleosis due to cytomegalovirus. J. Infect. Dis. 136:1977;667-678.
29. Turtinen L.W., Saltzman R., Jordan M.C., Haase A.T. Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb. Pathog. 3:1987;287-297.
30. Saltzman R.L., Quirk M.R., Jordan M.C. Disseminated cytomegalovirus infection - molecular analysis of virus and leukocyte interactions in viraemia. J. Clin. Invest. 81:1988;75-81.
31. Dankner W.M., McCutchan J.A., Richman D.D., Hirata K., Spector S.A. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J. Infect. Dis. 161:1990;31-36.
32. Grefte A., Harmsen M.C., van der Giessen M., Knollema S., van Son W.J., The T.H. Presence of human cytomegalovirus (HCMV) immediate-early mRNA but not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection. J. Gen. Virol. 75:1994;1989-1998.
33. Grundy J.E., Lawson K.M., MacCormac L.P., Fletcher J.M., Yong K.L. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J. Infect. Dis. 177:1998;1465-1474.
34. Einhorn L., Ost A. Cytomegalovirus infection in human blood cells. J. Infect. Dis. 149:1984;207-214.
35. Rice G.P.A., Schrier R.D., Oldstone M.B.A. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. USA. 81:1984;6134-6138.
36. Taylor-Wiedeman J.A., Sissons J.G.P., Borysiewicz L.K., Sinclair J.H.G. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:1991;2059-2064.
37. Ibanez C.E., Schrier R., Ghazal P., Wiley C., Nelson J.A. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65:1991;6581-6588.
38. Weinshenker B.G., Wilton S., Rice G.P.A. Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J. Immunol. 140:1988;1625-1631.
39. Lathey J.L., Spector S.A. Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J. Virol. 65:1991;6371-6375.
40. Taylor-Wiedeman J., Sissons P., Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1994;1597-1604.
41. Fish K.N., Britt W., Nelson J.A. A novel mechanism for persistence of human cytomegalovirus in macrophages. J. Virol. 70:1996;1855-1862.
42. Maidji E., Tugizov S., Abenes G., Jones T., Pereira L. A novel human cytomegalovirus glycoprotein, gpUS9, which promotes cell-to-cell spread in polarized epithelial cells, colocalizes with the cytoskeletal proteins E-cadherin and F-actin. J. Virol. 72:1998;5717-5727.
43. Waldman W.J., Knight D.A., Huang E.H., Sedmak D.D. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J. Infect. Dis. 171:1995;263-272.
44. Grefte A., van der Giessen M., van Son W., The T.H. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J. Infect. Dis. 167:1993;270-277.
45. Percivalle E., Revello M.G., Vago L., Morini F., Gerna G. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J. Clin. Invest. 92:1993;663-670.
46. Shahgasenpour S., Woodroffe S.B., Garnett H.M. Alterations in the expression of ELAM-1, ICAM-1 and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus. Microbiol. Immunol. 41:1997;121-129.
47. Watanabe M., Ito M., Kamiya H., Sakurai M. Adherence of peripheral blood leukocytes to cytomegalovirus-infected fibroblasts. Microbiol. Immunol. 40:1996;519-523.
48. Grundy J.E., Downes K.L. Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology. 78:1993;405-412.
49. Grundy J.E., Pahal G.S., Akbar A.N. Increased adherence of CD2 peripheral blood lymphocytes to cytomegalovirus-infected fibroblasts is blocked by anti-LFA-3 antibody. Immunology. 78:1993;413-420.
50. Murayama T., Kuno K., Jisaki F., Obuchi M., Sakamuro D., Furukawa T., Mukaida N., Matsushima K. Enhancement of human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J. Virol. 68:1994;7582-7585.
51. Kari B., Gehrz R. A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J. Virol. 66:1992;1761-1764.
52. Compton T., Nowlin D.M., Cooper N.R. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology. 193:1993;834-841.
53. Keay S., Baldwin B. Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment. J. Virol. 65:1991;5124-5128.
54. Keay S., Merigan T.C., Rasmussen L. Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus. Proc. Natl. Acad. Sci. USA. 86:1989;10100-10103.
55. Milne R.S.B., Paterson D.A., Booth J.C. Human cytomegalovirus glycoprotein H glycoprotein L complex modulates fusion-from-without. J. Gen. Virol. 79:1998;855-865.
56. Adlish J.D., Lahijani R.S., St Jeor S.C. Identification of a putative cell receptor for human cytomegalovirus. Virology. 176:1990;337-345.
57. Soderberg C., Larsson S., Rozell B.L., Sumitran-Karuppan S., Ljungman P., Moller E. Cytomegalovirus-induced CD13-specific autoimmunity - a positive cause of chronic graft-versus-host disease. Transplantation. 26:1996;600-609.
58. Wright J.F., Kurosky A., Wasi S. An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem. Biophys. Res. Commun. 198:1994;983-989.
59. Quinnan G.V., Delery M., Rook A.H., Frederick W.R., Epstein J.S., Manischewitz J.F., Jackson L., Ramsey K.M., Mittal K., Plotkin S.A., Hilleman M.R. Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann. Intern. Med. 101:1984;478-483.
60. Brown J.M., Kaneshima H., Mocarski E.S. Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J. Infect. Dis. 171:1995;1599-1603.
61. Waldman W.J., Roberts W.H., Davis D.H., Williams M.V., Sedmak D.D., Stephens R.E. Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells. Arch. Virol. 117:1991;143-164.
62. Chou S., Dennison K.M. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J. Infect. Dis. 163:1991;1229-1234.
63. Chou S. Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus. Virology. 188:1992;388-390.
64. Meyer-Konig U., Vogelberg C., Bongarts A., Kampa D., Delbruck R., Wolff-Vorbeck G., Kirste G., Haberland M., Hufert F.T., von Laer D. Glycoprotein G genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J. Med. Virol. 55:1998;75-81.
65. Shepp D.H., Match M.E., Lipson S.M., Pergolizzi R.G. A fifth human cytomegalovirus glycoprotein B genotype. Res. Virol. 149:1998;109-114.
66. Meyer-Konig U., Haberland M., von Laer D., Haller O., Hufert F.T. Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J. Infect. Dis. 177:1998;1162-1169.
67. Fries B.C., Chou S., Boeckh M., Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J. Infect. Dis. 169:1994;769-774.
68. Bongarts A., von Laer D., Vogelberg C., Ebert K., von Lunzen J., Garwegg J., Vaith P., Hufert F.T., Haller O., Meyer-Konig U. Glycoprotein B genotypes of human cytomegalovirus; distribution in HIV-infected patients. Scand. J. Infect. Dis. 28:1996;447-449.
69. Cha T.A., Tom E., Kemble G.W., Duke G.M., Mocarski E.S., Spaete R.R. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:1996;78-83.
70. Grundy J.E. Virologic and pathogenetic aspects of cytomegalovirus infection. Rev. Infect. Dis. 12:1990;S711-S719.
71. Mocarski E.S., Kemble G.W. Recombinant cytomegaloviruses for study of replication and pathogenesis. Intervirology. 39:1996;320-330.
72. Greaves R.F., Mocarski E.S. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol. 72:1998;366-379.
73. Lagenaur L.A., Manning W.C., Veiera J., Martens C.L., Mocarski E.S. Structure and function of the murine cytomegalovirus ssg1 gene: a determinant of viral growth in salivary gland acinar cells. J. Virol. 68:1994;7717-7727.
74. Vieira J., Farrell H.E., Rawlinson W.D., Mocarski E.S. Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette. J. Virol. 68:1994;4837-4846.
75. Cavanaugh V.J., Stenberg R.M., Staley T.L., Virgin H.W., Macdonald M.R., Paetzold S., Farrell H.E., Rawlinson W.D., Campbell A.E. Murine cytomegalovirus with a deletion of genes spanning HindIII-J and HindIII-I displays altered cell and tissue tropism. J. Virol. 70:1996;1365-1374.
76. Davis-Poynter N.J., Lynch D.M., Vally H., Shellam G.R., Rawlinson W.D., Barrell B.G., Farrell H.E. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J. Virol. 71:1997;1521-1529.
77. Beisser P.S., Vink C., Van Dam J.G., Grauls G., Vanherle S.J.V., Bruggeman C.A. The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. J. Virol. 72:1998;2352-2363.
78. Boname, J.M., Jagenaur, L.A. and Mocarski, E.S. (1994) Murine cytomegalovirus genes influencing virus growth and tropism for salivary gland. In: Pathogenicity of Human Herpesviruses due to Specific Pathogenicity Genes (Becker, Y. and Darai, G., Eds.), pp. 315-328. Springer-Verlag, Berlin, Germany.
79. Thale R., Lucin P., Schneider K., Eggers M., Koszinowski U.H. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J. Virol. 68:1994;7757-7765.
80. Farrell H.E., Vally H., Lynch D.M., Fleming P., Shellam G.R., Scalzo A.A., Davis-Poynter N.J. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature. 386:1997;510-514.
81. Browne H., Churcher M., Minson T. Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. J. Virol. 66:1992;6784-6787.
82. Conn C.A., Mcclellan J.L., Maassab H.F., Smitka C.W., Majde J.A., Kluger M.J. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 37:1995;R78-R84.
83. Stenberg R.M., Thomsen D.R., Stinski M.F. Structural analysis of the major immediate early gene of human cytomegalovirus. J. Virol. 49:1984;190-199.
84. Baskar J.F., Smith P.P., Nilaver G., Jupp R.A., Hoffmann S., Peffer N.J., Tenney D.J., Colberg-Poley A.M., Ghazal P., Nelson J.A. The enhancer domain of the human cytomegalovirus major immediate- early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70:1996;3207-3214.
85. Angulo A., Chandraratna R.A.S., Leblanc J.F., Ghazal P. Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus. J. Virol. 72:1998;4589-4600.
86. Angulo A., Suto C., Boehm M.F., Heyman R.A., Ghazal P. Retinoid activation of retinoic acid receptors but not retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J. Virol. 69:1995;3831-3837.
87. Quinnan G.V., Manischewitz J.E. The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J. Exp. Med. 150:1979;1549-1554.
88. Bancroft G.J., Shellam G.R., Chalmer J.E. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126:1981;988-994.
89. Shellam G.R., Allan J.E., Papadimitriou J.M., Bancroft G.J. Increased susceptibility to cytomegalovirus infection in beige mice. Proc. Natl. Acad. Sci. USA. 78:1981;5104-5108.
90. Bukowski J.F., Woda B.A., Welsh R.M. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52:1984;119-128.
91. Welsh R.M., Brubaker J.O., Vargas-Cortes M., O'Donnell C.L. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J. Exp. Med. 173:1991;1053-1063.
92. Scalzo A.A., Fitzgerald N.A., Wallace C.R., Gibbons A.E., Smart Y.C., Burton R.C., Shellam G.R. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149:1992;581-589.
93. Allan J.E., Shellam G.R. Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch. Virol. 81:1984;139-139.
94. Manning W.C., Stoddart C.A., Lagenaur L.A., Abenes G.B., Mocarski E.S. Cytomegalovirus determinant of replication in salivary glands. J. Virol. 66:1992;3794-3802.
95. Biron C.A., Byron K.S., Sullivan J.S. Severe herpesvirus infections in an adolescent without natural killer cells. New Engl. J. Med. 320:1989;1731-1735.
96. Tay C.H., Szomolanyi-Tsuda E., Welsh R.M. Control of infections by NK cells. Curr. Top. Microbiol. Immunol. 230:1998;193-220.
97. Tay C.H., Welsh R.M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus by natural killer cells. J. Virol. 71:1997;267-275.
98. Orange J.S., Biron C.A. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK responses during murine cytomegalovirus infection. J. Immunol. 156:1996;4746-4756.
99. Reddehase M.J., Weiland F., Munch K., Jonjic S., Luske A., Koszinowski U.H. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:1985;264-273.
100. Reddehase M.J., Keil G.M., Koszinowski U.H. The cytolytic T lymphocyte response to the murine cytomegalovirus II. Detection of virus replication stage-specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors. Eur. J. Immunol. 14:1984;56-61.
101. Reddehase M.J., Koszinowski U.H. Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature. 312:1984;369-371.
102. Koszinowski U.H., Keil G.M., Schwarz H., Schickendanz J., Reddehase M.J. A non-structural polypeptide encoded by immediate-early transcription unit 1 of murine cytomegalovirus is recognized by cytolytic T lymphocytes. J. Exp. Med. 166:1987;289-294.
103. Koszinowski U.H., Reddehase M.J., Keil G.M., Volkmer H., Jonjic S., Messerle M., Del Val M., Mutter W., Munch K., Buhler B. Molecular analysis of herpes viral gene-products recognized by protective lymphocytes-T. Immunol. Lett. 16:1987;185-192.
104. Koszinowski U.H., Reddehase M.J., Keil G.M., Schickedanz J. Host immune response to cytomegalovirus: products of transfected viral immediate-early genes are recognised by cloned cytolytic T lymphocytes. J. Virol. 61:1987;2054-2058.
105. Volkmer H., Bertholet C., Jonjic S. Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus. J. Exp. Med. 166:1987;668-677.
106. Del Val M., Volkmer H., Rothbard J., Jonjic S., Messerle M., Schickedanz J., Reddehase M.J., Koszinowski U.H. Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. J. Virol. 62:1988;3965-3972.
107. Reddehase M.J., Rothbard J.B., Koszinowski U.H. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature. 337:1989;651-653.
108. Lathbury L.J., Allan J.E., Shellam G.R., Scalzo A.A. Effect of host genotype in determining the selective roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. J. Gen. Virol. 77:1996;2605-2613.
109. Jonjic S., Mutter W., Weiland F., Reddehase M.J., Koszinowski U.H. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4± T lymphocytes. J. Exp. Med. 169:1989;1199-1212.
110. + T lymphocytes. J. Virol. 64:1990;5457-5464.
111. Reddehase M.J., Keil G.M., Koszinowski U.H. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus. J. Immunol. 132:1984;482-489.
112. Holtappels R., Podlech J., Geginat G., Steffens H.-P., Thomas D., Reddehase M.J. Control of murine cytomegalovirus in the lungs: relative but not absolute dominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. J. Virol. 72:1998;7201-7212.
113. Quinnan G.V., Kirmoni N., Rook A.H., Manischewitz J.F., Jackson L., Moreschi G., Santos G.W., Saral R., Burns W.H. Cytotoxic T cells in cytomegalovirus infection. HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. New Engl. J. Med. 307:1982;7-13.
114. Davignon J.L., Castanie P., Yorke J.A., Gautier N., Clement D., Davrinche C. Anti-human cytomegalovirus activity of cytokines produced by CD4(+) T-cell clones specifically activated by IE1 peptides in vitro. J. Virol. 70:1996;2162-2169.
115. Borysiewicz L.K., Hickling J.K., Graham S., Sinclair J., Cranage M.P., Smith G.L., Sissons J.G.P. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD early protein and glycoprotein B expressed by recombinant vaccinia virus. J. Exp. Med. 168:1988;919-932.
116. Gilbert M.J., Riddell S.R., Li C.-R., Greenberg P.D. Selective interference with class I major histocompatability complex presentation of the major immediate-early proteins following infection with human cytomegalovirus. J. Virol. 67:1993;3461-3469.
117. Greenberg P.D., Reusser P., Goodrich J.M., Riddell S.R. Development of a treatment regimen for human cytomegalovirus (CMV) in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro. Ann. New York Acad. Sci. 636:1991;184-195.
118. Riddell S.R., Watanabe K.S., Goodrich J.M., Li C.R., Agha M.E., Greenberg P.D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 257:1992;238-241.
119. Beninga J., Kropff B., Mach M. Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response. J. Gen. Virol. 76:1995;153-160.
120. +) virus-specific cytotoxic T lymphocytes. J. Med. Virol. 43:1994;103-110.
121. Boppana S.B, Britt W.J. Recognition of human cytomegalovirus products by HCMV-specific cytotoxic T cells. Virology. 222:1996;293-296.
122. Alp N.J., Allport T.D., Vanzanten J., Rodgers B., Sissons J.G.P., Borysiewicz L.K. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein. J. Virol. 65:1991;4812-4820.
123. He H.L., Rinaldo C.R., Morel P.A. T cell proliferative responses to 5 human cytomegalovirus proteins in healthy seropositive individuals: implications for vaccine development. J. Gen. Virol. 76:1995;1603-1610.
124. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., Riddell S.R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New Engl. J. Med. 333:1995;1038-1044.
125. Jahn G., Kouzarides T., Mach M., Scholl B.C., Plachter B., Traupe B., Preddie E., Satchwell S.C., Fleckenstein B., Barrell B.G. Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. J. Virol. 61:1987;1358-1367.
126. Jahn G., Scholl B.C., Traupe B., Fleckenstein B. The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. J. Gen. Virol. 68:1987;1327-1337.
127. Landini M.P., Re M.C., Mirolo G., Baldassarri B., La Placa M. Human immune response to cytomegalovirus polypeptides studied by immunoblotting. J. Med. Virol. 17:1985;303-311.
128. Pande H., Campo K., Tanamachi B., Zaia J.A. Human cytomegalovirus strain Towne pp65 gene: nucleotide sequence and expression on Escherichia coli. Virology. 182:1991;220-228.
129. Zaia J.A., Forman S.J., Ting Y.P., Vanderwal-Urbina E., Blume K.G. Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. J. Infect. Dis. 153:1986;780-787.
130. Cramner L.D., Clark C.L., Spector D.H. Cloning, characterization, and expression of the murine cytomegalovirus homologue of the human cytomegalovirus 28-kDa matrix phosphoprotein (UL99). Virology. 205:1994;417-429.
131. Cramner L.D., Clark C.L., Morello C.S., Farrell H.E., Rawlinson W.D., Spector D.H. Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins. J. Virol. 70:1996;7929-7939.
132. Jonjic S., Pavic I., Polic B., Crnkovic I., Lucin P., Koszinowski U.H. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179:1994;1713-1717.
133. Rapp, M., Messerle, M., Lucin, P. and Koszinowski, U.H. (1993) In vivo protection studies with MCMV glycoprotein gB and gH expressed by vaccinia virus. In: Multidisciplinary Approach to Understanding Cytomegalovirus Disease (Michelson, S. and Plotkin, S.A., Eds.), pp. 327-332. Excerpta Medica, Amsterdam, The Netherlands.
134. Adler S.P., Starr S.E., Plotkin S.A., Hempfling S.H., Buis J., Manning M.L., Best A.M. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J. Infect. Dis. 171:1995;26-32.
135. Fowler K.B., Stagno S., Pass R.F., Britt W.J., Boll T.J., Alford C.A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. New Engl. J. Med. 326:1992;663-667.
136. Tanaka A., Moriuchi H., Hirota K., Numzaki Y. Neutralizing antibody response to cytomegalovirus in seropositive pregnant women. J. Med. Virol. 34:1991;85-88.
137. Rubin R.H. Impact of cytomegalovirus infection on organ transplant recipients. Rev. Infect. Dis. 12:(Suppl. 7):1990;S754-S766.
138. Zaia J.A. Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. Clin. Infect. Dis. 17:(Suppl. 2):1993;392-399.
139. Hengel H., Brune W., Koszinowski U.H. Immune evasion by cytomegalovirus - survival strategies of a highly adapted opportunist. Trends Microbiol. 6:1998;190-197.
140. Davis-Poynter N.J., Farrell H.E. Human and murine cytomegalovirus evasion of cytotoxic T lymphocytes and Natural Killer cell-mediated immune responses. Semin. Virol. 8:1998;369-376.
141. Wiertz E.J.H.J., Hill A., Tortorella D., Ploegh H. Cytomegaloviruses use multiple mechanisms to elude the host immune response. Immunol. Lett. 57:1997;213-216.
142. Gilbert M.J., Riddell S.R., Plachter B., Greenberg P.D. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature. 383:1996;720-722.
143. Ahn K.S., Angulo A., Ghazal P., Peterson P.A., Yang Y., Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA. 93:1996;10990-10995.
144. Jones T.R., Wiertz E.J.H.J., Sun L., Fish K.N., Nelson J.A. Human cytomegalovirus US3 impairs transport and maturation of major histocompatability complex class I heavy chains. Proc. Natl. Acad. Sci. USA. 93:1996;11327-11333.
145. Wiertz E.J.H.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., Ploegh H.L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 84:1996;769-779.
146. Jones T.R., Hanson L.K., Sun L., Slater J.S., Stenberg R.M., Campbell A.E. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatability complex class I heavy-chains. J. Virol. 69:1995;4830-4841.
147. Wiertz E.J.H.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., Ploegh H.L. Sec61-mediated transfer of a membrane protein from the endoplastic reticulum to the proteasome for destruction. Nature. 384:1996;432-438.
148. Hengel H., Flohr T., Hammerling G.J., Koszinowski U.H., Momburg F. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J. Gen. Virol. 77:1996;2287-2296.
149. Hengel H., Koopman J.O., Flohr T., Muranyi W., Goulmy E., Hammerling G.J., Koszinowski U.H., Momburg F. A viral ER-resistant glycoprotein inactivates the MHC-encoded peptide transporter. Immunity. 6:1997;623-632.
150. Ahn K., Gruhler A., Galocha B., Jones T.R., Mai J.H.J., Ploegh H.L., Peterson P.A., Yang Y., Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 6:1997;613-621.
151. Lehner P.J., Karttunen J.T., Wilkinson G.W.G., Cresswell P. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA. 94:1997;6904-6909.
152. Ziegler H., Thale R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrell H., Rawlinson W., Koszinowski U.H. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity. 6:1997;57-66.
153. Slater J.S., Campbell A.E. Down-regulation of MHC class I synthesis by murine cytomegalovirus occurs in immortalized but not primary fibroblasts. Virology. 229:1997;221-227.
154. Miller D.M., Rahill B.M., Boss J.M., Lairmore M.D., Durbin J.E., Waldman W.J., Sedmak D.D. Human cytomegalovirus inhibits major histocompatability complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:1998;675-683.
155. Heise M.T., Pollock J.L., Oguin A., Barkon M.L., Bromley S., Virgin H.W. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon. Virology. 241:1998;331-344.
156. Colonna M. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol. Rev. 155:1997;127-133.
157. Brutkiewicz R.R., Welsh R.M. Major histocompatability complex class I antigens and the control of viral infections by natural killer cells. J. Virol. 69:1995;3967-3971.
158. Beck S., Barrell B.G. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-1 antigens. Nature. 331:1988;269-272.
159. Reyburn H.T., Mendelboim O., Vales-Gomez M., Davis D.M., Pazmany L., Strominger J.L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature. 386:1997;514-517.
160. Margulies B.J., Browne H., Gibson W. Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology. 225:1996;111-125.
161. Bodaghi B., Jones T.R., Zipeto D., Vita C., Sun L., Laurent L., Arenzana-Seisdedos F., Virelizier J.-L., Michelson S. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. Med. 188:1998;855-866.
162. Vieira J., Schall T.J., Corey L., Geballe A.P. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J. Virol. 72:1998;8158-8165.
163. Neote K., DiGregorio D., Mak J.Y., Horuk R., Schall T.J. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine. Cell. 72:1993;415-425.
164. Gao J.-L., Murphy P.M. Human cytomegalovirus open reading frame US28 encodes a functional β chemokine receptor. J. Biol. Chem. 269:1994;28539-28542.
165. Furukawa T., Hornberger E., Sakuma S., Plotkin S.A. Demonstration of immunoglobulin G receptors induced by human cytomegalovirus. J. Clin. Microbiol. 2:1975;332-336.
166. MacCormac L.P., Grundy J.E. Human cytomegalovirus induces an Fc γ receptor (FcγR) in endothelial cells and fibroblasts that is distinct from the human cellular FcγRs. J. Infect. Dis. 174:1996;1151-1161.
167. Stannard L.M., Hardie D.R. An Fc receptor for human immunoglobulin G is located within the tegument of human cytomegalovirus. J. Virol. 65:1991;3411-3415.
168. Xu -B., Murayama T., Ishida K., Furukawa T. Characterization of IgG Fc receptors induced by human cytomegalovirus. J. Gen. Virol. 70:1989;893-900.
169. Dubin G., Socolof E., Frank I., Friedman H.M. Herpes simplex type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J. Virol. 65:1991;7046-7050.
170. Frank I., Friedman H.M. A novel function of the Herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J. Virol. 63:1989;4479-4488.
171. Spiller O.B., Morgan B.P., Tufaro F., Devine D.V. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. Eur. J. Immunol. 26:1996;1532-1538.
172. Spear G.T., Lurain N.S., Parker C.J., Ghassemi M., Payne G.H., Saifuddin M. Host cell-derived complement control proteins CD55 and CD59 are incorporated into virions of two unrelated envelope viruses: human T cell leukemia/lymphoma virus type 1 (HTLV-1) and human cytomegalovirus (HCMV). J. Immunol. 155:1995;4376-4381.
173. Schoppel K., Kropff B., Schmidt C., Vornhagen R., Mach M. The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies. J. Infect. Dis. 175:1997;533-544.
174. Leong C.C., Chapman T.L., Bjorkman P.J., Formankova D., Mocarski E.S., Phillips J.H., Lanier L.L. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatability complex and a viral class I homolog. J. Exp. Med. 187:1998;1681-1687.
175. Fletcher J.M., Prentice H.G., Grundy J.E. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. J. Immunol. 161:1998;2365-2374.
176. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., Hsu M.-L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7:1997;273-282.
177. Tay C.H., Welsh R.M., Brutkiewicz R.R. NK cell response to viral infections in beta-2-microglobulin-deficient mice. J. Immunol. 154:1995;780-789.
178. Browne H., Smith G., Beck S., Minson T. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta-2 microglobulin. Nature. 347:1990;770-772.
179. Fahnestock M.L., Johnson J.L., Feldman R.M.R., Neveu J.M., Lane W.S., Bjorkman P.J. The MHC class-I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity. 3:1995;583-590.
180. Chapman T.L., Bjorkman P.J. Characterization of a murine cytomegalovirus class I major histocompatability complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J. Virol. 72:1998;460-466.
181. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. Structure of the human class I histocompatability antigen, HLA-A2. Nature. 329:1987;506-512.
182. Hengel H., Esslinger C., Pool J., Goulmy E., Koszinowski U.H. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J. Gen. Virol. 76:1995;2987-2997.
183. Kleijnen M.F., Huppa J.B., Lucin P., Mukherjee S., Farrell H., Campbell A.E., Koszinowski U.H., Hill A.B., Ploegh H.L. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16:1997;685-694.
184. Crnkovic-Mertens I., Messerle M., Milotic I., Szepan U., Kucic N., Krmpotic A., Jonjic S., Koszinowski U.H. Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J. Virol. 72:1998;1377-1382.
185. Banks T.A., Rouse B.T. Herpesviruses - immune escape artists. Clin. Infect. Dis. 14:1992;933-941.
186. Ho M., Suwansirikul S., Dowling J.N., Youngblood L.A., Armstrong J.A. The transplanted kidney as a source of cytomegalovirus infection. New Engl. J. Med. 293:1975;1109-1112.
187. Betts R.F., Freeman R.B., Douglas R.G., Talley T.E., Rundell B. Transmission of cytomegalovirus infection with renal allograft. Kidney Int. 8:1975;387-394.
188. Pollard R.B., Arvin A.M., Gamberg P., Rand K.H., Gallagher J.G., Merigan T.C. Specific cell-mediated immunity and infections with Herpes viruses in cardiac transplant recipients. Am. J. Med. 73:1982;679-687.
189. Singh N., Dummer J.S., Kusne S., Breinig M.K., Armstrong J.A., Makowka L., Starzl M., Ho M. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J. Infect. Dis. 158:1988;124-131.
190. Furukawa T., Jisaki F., Sakamuro D., Takegami T., Murayama T. Detection of human cytomegalovirus genome in uterus tissue. Arch. Virol. 135:1994;265-277.
191. Melnick J.L., Hu C., Burek J., Adam E., Debaskey M.E. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 42:1994;170-174.
192. Cheung K.S., Lang D.J. Transmission and activation of cytomegalovirus with blood transfusion: a mouse model. J. Infect. Dis. 135:1977;841-845.
193. Rubin R.H., Wilson E.J., Barrett L.V., Medearis D.N. Primary cytomegalovirus infection following cardiac transplantation in a murine model. Transplantation. 37:1984;306-310.
194. Balthesen M., Messerle M., Reddehase M.J. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67:1993;5360-5366.
195. Collins T., Pomeroy C., Jordan M.C. Detection of latent cytomegalovirus DNA in diverse organs of mice. J. Infect. Dis. 168:1993;725-729.
196. Klotman M.E., Henry S.C., Greene E.C., Brazy P.C., Klotman P.E., Hamilton J.D. Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. J. Infect. Dis. 161:1990;220-225.
197. Mercer J.A., Wiley C.A., Spector D.H. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J. Virol. 62:1988;987-997.
198. Cheung K.S., Lang D.J. Detection of latent cytomegalovirus in murine salivary and prostate explant cultures and cells. Infect. Immun. 15:1977;568-575.
199. Hamilton J.D., Seaworth B.J. Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model. Transplantation. 39:1985;290-296.
200. + bone marrow progenitors. J. Gen. Virol. 77:1996;3099-3102.
201. Minton E.J., Tysoe C., Sinclair J.H., Sissons J.G.P. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:1994;4017-4021.
202. Stanier P., Taylor D.L., Kitchen A.D., Wales N., Tryhorn Y., Tyms A.S. Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. Br. Med. J. 29:1989;897-898.
203. Hahn G., Jores R., Mocarski E.S. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA. 95:1998;3937-3942.
204. Kondo K., Xu J.K., Mocarski E.S. Human cytomegalovirus latent gene-expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. USA. 93:1996;11137-11142.
205. Kondo K., Kaneshima H., Mocarski E.S. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA. 91:1994;11879-11883.
206. Maciejewski J.P., Bruening E.E., Donahue R.E., Mocarski E.S., Young N.S., St Jeor S.C. Infection of hemopoietic progenitor cells by human cytomegalovirus. Blood. 80:1992;170-178.
207. Gnann J.W., Ahlmen J., Svalander C., Olding L., Oldstone M.B.A., Nelson J.A. Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am. J. Pathol. 132:1988;239-248.
208. Hendrix M.G.R., Daeman M., Bruggerman C.A. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am. J. Pathol. 13:1991;563-567.
209. Fish K.N., Soderberg-Naucler C., Mills L.K., Stenglein S., Nelson J.A. Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol. 72:1998;5661-5668.
210. Koffron A.J., Hummel M., Patterson B.K., Yan S.X., Kaufman D.B., Fryer J.P., Stuart F.P., Abecassis M.I. Cellular localization of latent murine cytomegalovirus. J. Virol. 72:1998;95-103.
211. Mitchell B.M., Leung A., Stevens J.G. Murine cytomegalovirus DNA in peripheral blood of latently infected mice is detectable only in monocytes and polymorphonuclear leukocytes. Virology. 223:1996;198-207.
212. Pollock J.L., Presti R.M., Paetzold S., Virgin H.W. Latent murine cytomegalovirus infection in macrophages. Virology. 227:1997;168-179.
213. Brautigan A.R., Dutko F.J., Olding L.B., Oldstone M.B.A. Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J. Gen. Virol. 44:1979;349-359.
214. Kurz S., Steffens H.P., Mayer A., Harris J.R., Reddehase M.J. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:1997;2980-2987.
215. Pomeroy C., Hilleren P.J., Jordan M.C. Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J. Virol. 65:1991;3330-3334.
216. Rock D.L., Fraser N.W. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature. 302:1983;523-525.
217. Lindahl T., Adams A., Bjursell G., Bornkamm G.W., Kaschka-Dierich C., Jehn U. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J. Mol. Biol. 102:1976;511.
218. Balthesen M., Dreher L., Lucin P., Reddehase M.J. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. J. Gen. Virol. 75:1994;2329-2336.
219. Reddehase M.J., Balthesen M., Rapp M., Jonjic S., Pavic I., Koszinowski U.H. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:1994;185-193.
220. Schrier R.D., Nelson J.A., Oldstone M.B.A. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science. 230:1985;1048-1051.
221. Bitsch A., Kirchner H., Dupke R., Bein G. Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction. J. Infect. Dis. 167:1993;740-743.
222. Kondo K., Mocarski E.S. Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand. J. Infect. Dis. S99:1995;63-67.
223. Kramer M.F., Coen D.M. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69:1995;1389-1399.
224. Yuhasz S.A., Dissette V.B., Cook M.L., Stevens J.G. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology. 202:1994;272-280.
225. Henry S.C., Hamilton J.D. Detection of murine cytomegalovirus immediate early 1 transcripts in the spleens of latently infected mice. J. Infect. Dis. 167:1993;954-959.
226. Pollock J.L., Virgin H.W. Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J. Virol. 69:1995;1762-1768.
227. Stinski, M.F., Macias, M.P., Malone, C.L., Thrower, A.R. and Huang, L. (1993) Regulation of transcription from the cytomegalovirus major immediate early promoter by cellular and viral proteins. In: Multidisciplinary Approach to Understanding Cytomegalovirus Disease. (Michelson, S. and Plotkin, S.A., Eds.), pp. 3-12. Excerpta Medica, Amsterdam, The Netherlands.
228. Sinclair J.H., Baillie J., Bryant L.A., Taylor-Weideman J.A., Sissons J.G.P. Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line. J. Gen. Virol. 73:1992;433-435.
229. Wolff D., Sinzger C., Drescher P., Jahn G., Plachter B. Reduced levels of IE2 gene expression and shutdown of early and late viral genes during latent infection of the glioblastoma cell-line U138-MG with selectable recombinants of human cytomegalovirus. Virology. 204:1994;101-113.
230. Kemp L.M., Latchman D.S. Regulated transcription of herpes simplex virus immediate-early genes in neuroblastoma cells. Virology. 171:1989;607-610.
231. Minagawa H., Tanaka S., Toh Y., Mori R. Detection of herpes simplex type 1-encoded RNA by polymerase chain reaction: different pattern of viral RNA detection in latently infected murine trigeminal ganglia following in vitro and in vivo reactivation. J. Gen. Virol. 75:1994;647-650.
232. Sinclair J., Sissons J.G.P. Latent and persistent infections in monocytes and macrophages. Intervirology. 39:1996;293-301.
233. Kurz S.K., Rapp M., Steffens H.-P., Grzimek N.K.A., Schmalz S., Reddehase M.J. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J. Virol. 73:1999;482-494.
234. Furrarah A.M., Sweet C. Studies of the pathogenesis of wild-type virus and six temperature-sensitive mutants of mouse cytomegalovirus. J. Med. Virol. 43:1993;317-330.
235. Shelbourn S.L., Kathari S.K., Sissons J.G.P., Sinclair J.H. Repression of human cytomegalovirus gene expression associated with a novel immediate early regulatory region binding factor. Nucleic Acids Res. 17:1989;9165-9171.
236. Kothari S., Baillie J., Sissons J.G.P., Sinclair J.H. The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells. Nucleic Acids Res. 19:1991;1767-1771.
237. Liu R., Baillie J., Sissons J.G.P., Sinclair J.H. The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells. Nucleic Acids Res. 22:1994;2453-2459.
238. Stein J., Volk H.D., Liebenthal C., Kruger D.H., Prosch S. Tumor necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J. Gen. Virol. 74:1993;2333-2338.
239. Kline J.N., Hunninghake G.M., He B., Monick M.M., Hunninghake G.W. Synergistic activation of the human cytomegalovirus major immediate early promoter by prostaglandin E-2 and cytokines. Exp. Lung Res. 24:1998;3-14.
240. Allan-Yorke J., Record M., de Preval C., Davrinche C., Davignon J.-L. Distinct pathways for tumor necrosis alpha and ceramides in human cytomegalovirus infection. J. Virol. 72:1998;2316-2322.
241. Prosch S., Staak K., Stein J., Liebenthal C., Stamminger T., Volk H.-D., Kruger D.H. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFα is mediated via NF-κB. Virology. 1995;197-206.
242. Loser P., Jennings G.S., Strauss M., Sandig V. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFκB. J. Virol. 72:1998;180-190.
243. Yurochko A.D., Kowalik T.F., Huong S.M., Huang E.S. Human cytomegalovirus upregulates NF-kappa-b activity by transactivating the NF-κB p105/p50 and p65 promoters. J. Virol. 69:1995;5391-5400.
244. Zhu H., Shen Y.Q., Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:1995;7960-7970.
245. Cinatl J., Cinatl J., Vogel J.-U., Kotchetkov R., Driever P.H., Kabickova H., Kornhuber B., Schwabe D., Doerr H.W. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res. 58:1998;367-372.
246. Razvi E.S., Welsh R.M. Apoptosis in viral infections. Adv. Virus. Res. 45:1995;1-60.
247. Khan M.A., Gaylor V., Latif N., Lam K., Morrison K., Allen S., Yacoub M. Cytomegalovirus encodes a Bcl-2 homologue that binds Bax. FASEB J. 11:1997;56.
248. Iwamoto G.F.K., Monick M.M., Clark B.D., Auron P.E., Stinski M.F., Hunninghake G.W. Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus. J. Clin. Invest. 85:1990;1853-1857.
249. Smith P.D., Saini S.S., Raffeld M., Manischewitz J.F., Wahl S.M. Cytomegalovirus induction of tumor necrosis factor-a by human monocytes and mucosal macrophages. J. Clin. Invest. 90:1992;1642-1648.
250. Liles W.C., Kiener P.A., Ledbetter J.A., Aruffo A., Klebanoff S.J. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes. Implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184:1996;429-440.
251. Orange J.S., Salazar-Mather T.P., Opal S.M., Biron C.A. Mechanisms for virus-induced liver disease: tumor necrosis factor- mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J. Virol. 71:1997;9248-9258.
252. Rubin R.H., Tolkoff-Rubin N.E., Oliver D., Rota T.R., Hamilton J., Betts R.F., Pass R.F., Hillis W., Szmuness W., Farrell M., Hirsch M.S. Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation. 40:1985;243-249.
253. Gorensek M.J., Stewart R.W., Keys T.F., McHenry M.C., Goormastic M. A multivariant analysis of the risk of cytomegalovirus infection in heart transplant recipients. J. Infect. Dis. 157:1988;515-522.
254. Wingard J.R., Mellits E.D., Sostrin M.B., Chen D.Y.-H., Burns W.H., Santos G.W., Vriesendorp H.M., Beschorner W.E., Saral R. Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution. Medicine. 67:1988;175-186.
255. Grundy, J.E., Shanley, J.D. and Griffiths, P.D. (1987) Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet ii, pp. 996-999.
256. Hudson J.B. The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Arch. Virol. 62:1979;1-29.
257. Shanley J.D. Murine models of cytomegalovirus-associated pneumonitis. Transpl. Proc. 23:((S3)):1991;12-16.
258. Grundy J.E., Shanley J.D., Shearer G.M. Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplant. 39:1985;548-553.
259. Shanley J.D., Via C.S., Sharrow S.O., Shearer G.M. Interstitial pneumonitis during murine cytomegalovirus infection and graft-versus-host reaction. Characterization of bronchoalveolar lavage cells. Transplantation. 44:1987;658-662.
260. Shanley J.D., Pesanti E.L. The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection. J. Infect. Dis. 151:1985;454-458.
261. Tanaka K., Koga Y., Lu Y.Y., Zhang X.Y., Wang Y., Kimura G., Nomoto K. Murine cytomegalovirus - associated pneumonitis in the lungs free of the virus. J. Clin. Invest. 94:1994;1019-1025.
262. Shanley J.D., Thrall R.S., Forman S.J. Murine cytomegalovirus replication in the lungs of athymic BALB/c nude mice. J. Infect. Dis. 175:1997;309-315.
263. Tanaka K., Nakazawa H., Okada K., Umezawa K., Fukuyama N., Koga Y. Nitric oxide mediates murine cytomegalovirus-associated pneumonitis in lungs that are free of the virus. J. Clin. Invest. 100:1997;1822-1830.
264. Haagmans B.L., Stals F.S., van der Meide P.H., Bruggeman C.A., Horzinek M.C., Schijns V.E.C.J. Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. J. Virol. 68:1994;2297-2304.
265. Geist L.J., Monick M.M., Stinski M.F., Hunninghake G.W. The immediate-early genes of human cytomegalovirus up-regulate tumor necrosis factor-alpha gene expression. J. Clin. Invest. 93:1994;474-478.